FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362640955> ?p ?o ?g. }

• W4362640955 endingPage "368" @default.
• W4362640955 startingPage "363" @default.
• W4362640955 abstract "The treatment landscape of advanced prostate cancer (CaP) has evolved significantly over the past 20 years. As the number of oral anticancer treatment options continues to increase, so do the costs of these drugs. Furthermore, payment responsibility for these treatments is increasingly shifted from insurers to patients. In this narrative review, we sought to summarize existing assessments of financial toxicity (FT) associated with oral advanced CaP treatments, describe efforts targeted at limiting FT from these agents, and identify areas in need of further investigation. FT is understudied in advanced CaP. Oral treatment options are associated with significantly higher direct costs to patients compared to standard androgen deprivation therapy or chemotherapy. Financial assistance programs, Medicare low-income subsidies, and recent health policy changes help offset these costs for some patients. Physicians are reluctant to discuss treatment costs with patients and further work is needed to better understand best practices for inclusion of FT discussions in shared decision-making. Oral therapies for advanced CaP are associated with significantly higher patient out-of-pocket costs which may contribute to FT. Currently, little is known regarding the extent and severity of these costs on patients’ lives. While recent policy changes have helped reduce these costs for some patients, more work is needed to better characterize FT in this population to inform interventions that improve access to care and lessen the harms associated with the cost of novel treatments." @default.
• W4362640955 created "2023-04-07" @default.
• W4362640955 creator A5041418355 @default.
• W4362640955 creator A5063867635 @default.
• W4362640955 date "2023-09-01" @default.
• W4362640955 modified "2023-10-02" @default.
• W4362640955 title "Financial toxicity of oral therapies in advanced prostate cancer" @default.
• W4362640955 cites W127186983 @default.
• W4362640955 cites W1948287148 @default.
• W4362640955 cites W2050618903 @default.
• W4362640955 cites W2098919693 @default.
• W4362640955 cites W2100273578 @default.
• W4362640955 cites W2121508408 @default.
• W4362640955 cites W2129542001 @default.
• W4362640955 cites W2143401180 @default.
• W4362640955 cites W2154835844 @default.
• W4362640955 cites W2159778569 @default.
• W4362640955 cites W2192081476 @default.
• W4362640955 cites W2266198524 @default.
• W4362640955 cites W2292373964 @default.
• W4362640955 cites W2301857081 @default.
• W4362640955 cites W2413636075 @default.
• W4362640955 cites W2466406952 @default.
• W4362640955 cites W2541721407 @default.
• W4362640955 cites W2557299627 @default.
• W4362640955 cites W2608457900 @default.
• W4362640955 cites W2610433949 @default.
• W4362640955 cites W2615724680 @default.
• W4362640955 cites W2739191514 @default.
• W4362640955 cites W2761038984 @default.
• W4362640955 cites W2778096494 @default.
• W4362640955 cites W2786946813 @default.
• W4362640955 cites W2793834563 @default.
• W4362640955 cites W2795001216 @default.
• W4362640955 cites W2912386523 @default.
• W4362640955 cites W2943077196 @default.
• W4362640955 cites W2949042706 @default.
• W4362640955 cites W2999640375 @default.
• W4362640955 cites W3046070456 @default.
• W4362640955 cites W3086698624 @default.
• W4362640955 cites W3088974940 @default.
• W4362640955 cites W3137873333 @default.
• W4362640955 cites W3139733574 @default.
• W4362640955 cites W3208074867 @default.
• W4362640955 cites W3213147687 @default.
• W4362640955 cites W3215537850 @default.
• W4362640955 cites W4200457203 @default.
• W4362640955 cites W4206100491 @default.
• W4362640955 cites W4210253571 @default.
• W4362640955 cites W4213196409 @default.
• W4362640955 cites W4213419829 @default.
• W4362640955 cites W4223443163 @default.
• W4362640955 cites W4226245778 @default.
• W4362640955 cites W4229036764 @default.
• W4362640955 cites W767328070 @default.
• W4362640955 doi "https://doi.org/10.1016/j.urolonc.2023.03.002" @default.
• W4362640955 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37029039" @default.
• W4362640955 hasPublicationYear "2023" @default.
• W4362640955 type Work @default.
• W4362640955 citedByCount "0" @default.
• W4362640955 crossrefType "journal-article" @default.
• W4362640955 hasAuthorship W4362640955A5041418355 @default.
• W4362640955 hasAuthorship W4362640955A5063867635 @default.
• W4362640955 hasConcept C10138342 @default.
• W4362640955 hasConcept C121608353 @default.
• W4362640955 hasConcept C126322002 @default.
• W4362640955 hasConcept C144133560 @default.
• W4362640955 hasConcept C160735492 @default.
• W4362640955 hasConcept C162324750 @default.
• W4362640955 hasConcept C17744445 @default.
• W4362640955 hasConcept C177713679 @default.
• W4362640955 hasConcept C199539241 @default.
• W4362640955 hasConcept C2779703844 @default.
• W4362640955 hasConcept C2780192828 @default.
• W4362640955 hasConcept C2908647359 @default.
• W4362640955 hasConcept C50522688 @default.
• W4362640955 hasConcept C71924100 @default.
• W4362640955 hasConcept C84265765 @default.
• W4362640955 hasConcept C99454951 @default.
• W4362640955 hasConceptScore W4362640955C10138342 @default.
• W4362640955 hasConceptScore W4362640955C121608353 @default.
• W4362640955 hasConceptScore W4362640955C126322002 @default.
• W4362640955 hasConceptScore W4362640955C144133560 @default.
• W4362640955 hasConceptScore W4362640955C160735492 @default.
• W4362640955 hasConceptScore W4362640955C162324750 @default.
• W4362640955 hasConceptScore W4362640955C17744445 @default.
• W4362640955 hasConceptScore W4362640955C177713679 @default.
• W4362640955 hasConceptScore W4362640955C199539241 @default.
• W4362640955 hasConceptScore W4362640955C2779703844 @default.
• W4362640955 hasConceptScore W4362640955C2780192828 @default.
• W4362640955 hasConceptScore W4362640955C2908647359 @default.
• W4362640955 hasConceptScore W4362640955C50522688 @default.
• W4362640955 hasConceptScore W4362640955C71924100 @default.
• W4362640955 hasConceptScore W4362640955C84265765 @default.
• W4362640955 hasConceptScore W4362640955C99454951 @default.
• W4362640955 hasIssue "9" @default.
• W4362640955 hasLocation W43626409551 @default.
• W4362640955 hasLocation W43626409552 @default.

• next